Open AccessTREATMENT OF VERTIGO- WITH & WITHOUT ANXIOLYTIC DRUG (ALPRAZOLAM 0.25MG)
Author(s) -
Muhammad Ayub,
Syed Bukhari,
Mohsin Raza,
Asma Waqas,
Beenish Hassan Khan,
Atif Najam
Publication year - 2021
Publication title -
pakistan armed forces medical journal
Language(s) - English
Resource type - Journals
eISSN - 2411-8842
pISSN - 0030-9648
DOI - 10.51253/pafmj.v1i1.7922
Subject(s) - alprazolam , vertigo , medicine , anxiolytic , anxiety , beck anxiety inventory , randomized controlled trial , anesthesia , psychiatry , surgery , beck depression inventory
Objective: To compare the effect of using the tablet Alprazolam 0.25mg in the treatment outcome of vertigo related anxiety by beck anxiety inventory.
Study Design: Comparative study.
Place and Duration of Study: Combined Military Hospital Okara Cantt, Sep 2018 to Jun 2020.
Methodology: A total of 384 patients were included in the study. They were randomly assigned to group A and B by randomized clinical trial. Group A was given tablet alprazolam 0.25 mg along with the conventional treatment of vertigo and group B was given the treatment of vertigo only and no anxiolytic was added. Their pre & post treatment (after 2 weeks) anxiety level using Beck anxiety inventory was scored.
Results: There was a significant improvement in group A patient’s vertigo effects after treatment with alprazolam. Also, it was observed that group A patients responded significant improvement in anxiety score as compared to Group B patients 02 weeks post treatment.
Conclusion: Antianxiety treatment should be added in all cases with the conventional treatment of vertigo to reduce the vertigo associated anxiety of the patients.